Company Filing History:
Years Active: 2008
Title: Matthias Selke: Innovator in Organometallic Complexes
Introduction
Matthias Selke is a prominent inventor based in South Pasadena, CA (US). He has made significant contributions to the field of organometallic chemistry, particularly in the development of complexes that serve as singlet oxygen sensitizers. His innovative work has implications for various applications, including photodynamic therapy and environmental sensing.
Latest Patents
Selke holds a patent for "Organometallic complexes as singlet oxygen sensitizers." This patent describes a series of organometallic complexes and their singlet oxygen sensitization properties. The complexes with acetylacetonate ligands exhibit singlet oxygen quantum yields near unity, whether exciting the ligand-based state or the lowest energy excited state (MLCT+LC). The singlet oxygen quenching rates for these β-diketonate complexes are notably small, approximately three orders of magnitude slower than the corresponding phosphorescence quenching rate. Additionally, similar complexes were synthesized with glycine or pyridine tethered to the Ir(III) center, resulting in high singlet oxygen yields.
Career Highlights
Matthias Selke is affiliated with the University of Southern California, where he continues to advance research in organometallic chemistry. His work has garnered attention for its innovative approach to sensitizing singlet oxygen, which is crucial for various scientific and medical applications.
Collaborations
Selke has collaborated with notable colleagues, including Mark Edward Thompson and Peter I Djurovich. These partnerships have enriched his research and contributed to the advancement of knowledge in the field.
Conclusion
Matthias Selke's contributions to organometallic chemistry and his innovative patent on singlet oxygen sensitizers highlight his role as a leading inventor in this specialized area. His work continues to influence both academic research and practical applications in science.